Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction

Completed

Conditions studied: Chemotherapy-Induced Gut Barrier Damage, Acute Leukemia

In brief

This is an observational study to collect stool, blood, and urine from acute leukemia patients undergoing induction chemotherapy in order to generate preliminary data regarding the association between microbiota and chemotherapy-induced gut barrier damage. This study consists of inpatient collections of blood, urine, and stool while the patients are undergoing inpatient induction therapy. Patients will not be scheduled for any additional procedures or testing beyond what is required for clinical care.

Key facts

Study ID

NCT03316456

Run by

Masonic Cancer Center, University of Minnesota

People needed

20

Starts

2017-08-22

Expected to finish

2019-04-01

Last updated by the study team

2019-05-06

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (ages 18 - 99 years) undergoing inpatient induction chemotherapy for newly diagnosed or relapsed acute leukemia (myeloid or lymphoblastic).
• Any induction regimen (standard or experimental) with planned \~4 weeks of inpatient stay
• Able to provide written voluntary consent before performance of any study related procedure.

Where it is running

• Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.